Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB16951 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Mouse Monoclonal CRTAM Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects human CRTAM in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse CRTAM is observed.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 500 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references CADM1 is a key receptor mediating human mast cell adhesion to human lung fibroblasts and airway smooth muscle cells.
CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.
New B-cell CD molecules.
Moiseeva EP, Roach KM, Leyland ML, Bradding P
PloS one 2013;8(4):e61579
PloS one 2013;8(4):e61579
CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
Dessarthe B, Thedrez A, Latouche JB, Cabillic F, Drouet A, Daniel P, de La Pintière CT, Catros V, Toutirais O
Journal of immunology (Baltimore, Md. : 1950) 2013 May 1;190(9):4868-76
Journal of immunology (Baltimore, Md. : 1950) 2013 May 1;190(9):4868-76
Analysis of HLDA9 mAbs on plasmacytoid dendritic cells.
Cabezón R, Sintes J, Llinàs L, Benitez-Ribas D
Immunology letters 2011 Jan 30;134(2):167-73
Immunology letters 2011 Jan 30;134(2):167-73
New B-cell CD molecules.
Matesanz-Isabel J, Sintes J, Llinàs L, de Salort J, Lázaro A, Engel P
Immunology letters 2011 Jan 30;134(2):104-12
Immunology letters 2011 Jan 30;134(2):104-12
No comments: Submit comment
No validations: Submit validation data